NAV as on 27-03-2025
₹ 39.1
1D
Inception Returns
22.5%
/yr
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad. The fund could potentially beat inflation in the long-run.
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has given a CAGR return of 22.54% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 22.74%, 23.99% and 32.97% respectively.
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Divi's Laboratories Ltd, Aurobindo Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth has no lock in period.
Expense ratio | 1.11% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹4611 Cr |
Inception Date | 12 July, 2018 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 49.46% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
as on (27-Mar-25)
as on (28-Feb-25)
Top 3 Sectors in February were Health, Basic Materials & Financial Services
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 4.88% | 4.88% |
6 Month Returns | -5.94% | -5.94% |
1 Year Returns | 22.74% | 22.74% |
3 Years Returns | 90.63% | 23.99% |
5 Years Returns | 315.74% | 32.97% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth | 3.49 | 4.1 | 3.56 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth | 1.03 | 0.94 | 0.96 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth | 0.39 | 0.97 | 1.06 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth | 19.33 | 16.06 | 20.09 |